THERALINK TECHNOLOGIES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Theralink Technologies, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q4 2023.
  • Theralink Technologies, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 6.15B shares, unchanged year-over-year.
  • Theralink Technologies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 6.15B shares, a 4.6% increase from 2022.
  • Theralink Technologies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 5.88B shares, a 9.53% increase from 2021.
  • Theralink Technologies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 5.37B shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 6.15B +73 0% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 6.15B +270M +4.6% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-05
Q2 2023 6.15B +89.1M +1.47% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 6.15B +555M +9.92% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 6.15B +596M +10.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 5.88B Jul 1, 2022 Sep 30, 2022 10-K 2024-01-05
Q2 2022 6.06B +512M +9.22% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 5.6B +351M +6.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 5.56B Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-21
Q2 2021 5.55B +5.55B +1429230% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 5.24B +5.24B +592635% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q2 2020 388K* +220K +130% Apr 1, 2020 Jun 30, 2020 10-Q 2021-06-11
Q1 2020 885K +508K +135% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q4 2019 495K Oct 1, 2019 Dec 31, 2019 10-K 2020-03-25
Q3 2019 427K +99K +30.2% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-19
Q2 2019 168K* -229M -99.9% Apr 1, 2019 Jun 30, 2019 10-Q 2021-06-11
Q1 2019 377K* -177M -99.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 328K* -140M -99.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 230M +96.7M +72.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 177M +97.2M +122% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 129M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 140M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 133M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 79.6M Jan 1, 2017 Mar 31, 2017 10-Q 2018-06-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.